Streetbeat News

Stock Prices

TSLA

Tesla's (NYSE:TSLA) short percent of float has risen 5.74% since its last report, with 96.48 million shares sold short, which is 3.5% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a stock. However, compared to its peers, Tesla has less short interest as a percentage of float, with an average of 11.02%.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 2:46 pm

TEAM

Atlassian's (NYSE:TEAM) short percent of float has decreased by 6.3% since its last report, with 5.15 million shares sold short, representing 3.87% of all regular shares available for trading. It would take traders 2.4 days on average to cover their short positions. The company's short interest is higher than its peer group average of 3.39%.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 2:46 pm

SNY

Sanofi's (NYSE:SNY) short percent of float has risen 13.33% since its last report, with 4.24 million shares sold short, which is 0.17% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a particular stock. However, compared to its peers, Sanofi has less short interest as a percentage of float, which is 3.56% on average.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 2:46 pm

MA

Mastercard (NYSE:MA) has announced a quarterly dividend of 57 cents per share. The ex-dividend date is Thursday, meaning the stock will likely open 57 cents lower to reflect the payout. Shareholders who own MA as of the end of Wednesday's session are eligible to receive the dividend, which will be paid out on August 09, 2023.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 2:45 pm

AZN

ECX

Several US stocks recorded losses on Monday, with Protagonist Therapeutics, TOP Financial Group, Icosavax, Astrotech Corporation, Rackspace Technology, Avadel Pharmaceuticals, AstraZeneca, GDEV, ECARX Holdings, MediaAlpha, Smith & Nephew, and BlackBerry all seeing their share prices drop. Notably, AstraZeneca's shares fell 7.4% after it reported high-level results from a Phase 3 trial, and ECARX Holdings announced its intention to increase its investment in JICA Intelligent Robotics.

Portfolio Pulse from Lisa Levin

July 03, 2023 | 2:41 pm

RIG

Transocean Ltd. (RIG) shares continue to rise, marking an upward trend over the last five trading sessions. The stock has seen a volatile June, with a 14% increase over the last 30 days. The company recently announced a $184 million award for the Transocean Equinox in Australia, which could extend its operations there until 2028. RIG is popular among retail investors and is a top trending ticker on StockTwits. Over 19.9% of available shares are being sold short.

Portfolio Pulse from Erica Kollmann

July 03, 2023 | 2:41 pm

CCL

Carnival Corp (CCL) shares are trading higher following a better-than-expected earnings report. The company reported quarterly losses of 31 cents per share, beating the analyst consensus estimate of a loss of 34 cents. Sales were $4.91 billion, exceeding the analyst consensus estimate of $4.77 billion by 2.96%. Adjusted FY23 EBITDA is projected to be between $4.10 billion and $4.25 billion. JP Morgan analyst Matthew Boss maintained Carnival with an Overweight and raised its price target from $16 to $18.

Portfolio Pulse from Henry Khederian

July 03, 2023 | 2:39 pm

NLSP

NLS Pharmaceutics announced that the FDA has reviewed the full protocol for the NLS-1031 study and the Institutional Review Board has approved the Phase 3 clinical trial protocol to evaluate Mazindol ER in patients. This news has led to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 2:33 pm

CGC

Canopy Growth has completed all conversions pursuant to the $100 million convertible debentures and provided an update to its balance sheet actions taken to date. This has led to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 2:33 pm

AZN

A significant bullish stance has been taken on AstraZeneca (NASDAQ:AZN) as indicated by unusual options activity. A total of 46 options trades were spotted, with 63% bullish and 36% bearish sentiment. The majority of these trades were puts, with a total amount of $2,823,650, and one call for $33,550. The targeted price range for AstraZeneca over the last 3 months has been between $35.0 to $72.5. The current price of AZN is down 7.2% at $66.42.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 2:31 pm